HARROW, INC. — Director's Dealing 2018

Oct 18, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Imprimis Pharmaceuticals, Inc. (IMMY)
CIK: 0001360214
Period of Report: 2018-10-15

Reporting Person: Kammer Robert J (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-10-15	Common Stock	S	10000	$3.00	Disposed	909827	Direct

Footnotes

F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan, as amended, adopted by the Reporting Person.